Multimodality MRI and Liquid Biopsy in Gliblastoma

Multimodality MRI and Liquid Biopsy in Gliblastoma

Brief description of study

We are seeking to enroll up to 30 subjects with newly diagnosed or recurrent GBM who will undergo a clinical brain MRI examination with and without contrast prior to surgery. Participants will also have a blood draw pre-operatively to collect samples for cfDNA and ctDNA analysis. MRI imaging will include an injection of intravenous infusion of 5 mg/kg ferumoxytol in addition to routine pre and post-contrast sequences after gadolinium injection. Subsequently, three different sites in the enhancing component of the tumor of each participant will be selected for intraoperative sampling based on hypointense signal on multi-echo gradient-recalled echo sequence that reflect ferumoxytol-induced signal drop.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    GBM,Glioblastoma,recurrent GBM
  • Age: Between 18 Years - 99 Years
  • Gender: All


Updated on 16 Oct 2020. Study ID: 843601

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center